Dextro-mequitamium iodide

Drug Profile

Dextro-mequitamium iodide

Latest Information Update: 12 Apr 2000

Price : $50

At a glance

  • Originator Malesci
  • Class Anti-inflammatories; Antiallergics; Antiasthmatics; Bronchodilators; Small molecules
  • Mechanism of Action Histamine H1 receptor antagonists; Muscarinic receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Allergic asthma; Allergic rhinitis

Most Recent Events

  • 12 Apr 2000 Discontinued-Preclinical for Allergic asthma in Italy (Inhalation)
  • 12 Apr 2000 Discontinued-Preclinical for Allergic rhinitis in Italy (Intranasal)
  • 10 May 1999 Preclinical development for Allergic asthma in Italy (Inhalation)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top